Navigation Links
Vion Reports 2008 First Quarter Results
Date:5/5/2008

NEW HAVEN, Conn., May 5 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (Nasdaq: VION) today announced financial results for the three-month period ended March 31, 2008.

The Company reported a net loss of $8.2 million, or $1.14 per share, for the three-month period ended March 31, 2008, compared with a net loss of $8.0 million, or $1.20 per share, for the same period in 2007. Weighted-average common shares outstanding for the three months ended March 31, 2008 and 2007 were 7.2 million and 6.6 million, respectively.

Operating expenses were reduced by $679,000 from $7.9 million in the 2007 quarter to $7.2 million in 2008. Interest expense increased by $766,000 over the prior year as the Company's Convertible Senior Notes, issued in February 2007, were outstanding for the entire quarter in 2008.

The Company reported ending the quarter with $55.2 million in cash and cash equivalents, sufficient to fund the Company's operations through the third quarter of 2009 based on the current operating plan. The Company also announced that it will pay the interest payment due August 15, 2008 on its Convertible Senior Notes in cash.

Alan Kessman, Chief Executive Officer, commented, "We continue to work on the New Drug Application (NDA) for Cloretazine(R) (VNP40101M). It remains our plan to file the NDA with the U.S. Food and Drug Administration in 2008."

On February 20, 2008, the Company implemented a one-for-ten reverse split of all outstanding shares of its common stock and a corresponding decrease in the number of shares of authorized common stock. Share and per share amounts contained herein are provided on a post-split basis.

Vion Pharmaceuticals, Inc. is committed to extending the lives and improving th
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. eResearchTechnology Reports First Quarter 2008 Results
2. MannKind Corporation Reports First Quarter Financial Results
3. Verenium Reports Financial Results for the First Quarter 2008
4. ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance
5. United Therapeutics Reports First Quarter 2008 Financial Results
6. Endocare Reports 2008 First Quarter Financial Results
7. AMICAS Reports Financial Results for the First Quarter Ended March 31, 2008
8. LeMaitre Vascular Reports Q1 2008 Revenue of $11.8 Million, a 20% Increase
9. Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights
10. Neurobiological Technologies Reports Receipt of $2.0 Million Royalty Payment for Quarterly Sales of Memantine
11. Alexion Reports First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... 2015  BioNano Genomics, Inc., the leader in genome ... as chief commercial officer. Salyer has more than 20 ... in life sciences. At BioNano, Salyer will oversee the ... platform to assemble a comprehensive view of complex genomes ... 32 institutions located in the United States ...
(Date:3/26/2015)... BOSTON , March 26, 2015 /PRNewswire/ ... ), a global clinical research organization ... signed a definitive agreement to acquire all ... India ("QSI"), a leading provider of specialized ... refers to the collection, detection, assessment, monitoring, ...
(Date:3/26/2015)... Gicqueau, Founder and President of Clinovo, will co-present with ... on “ Conducting Postmarket Registries - Rationale and Execution ... Exhibition on April 25th through April 28th in Salt ... Ale Gicqueau and Victor Chen will discuss the rationale ... and resources to conduct the registry, as well as ...
(Date:3/25/2015)... Agnition announced today that it will be ... for the first time at 7:30 a.m. CST March ... explore the extremely important role soil microbes perform in ... Microbial Catalyst™ technology that enhances soil and plant health ... air again on April 28. , A biochemist at ...
Breaking Biology Technology:BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 2BioNano Genomics Appoints Terry Salyer as Chief Commercial Officer 3PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 2PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 3PAREXEL Announces Execution of Definitive Agreement to Acquire Quantum Solutions India, Strengthening Leadership In Pharmacovigilance Services 4Clinovo Presents at ACRP 2015 in Salt Lake City, Utah on April 25th-28th 2Clinovo Presents at ACRP 2015 in Salt Lake City, Utah on April 25th-28th 3Agnition to be Featured In Upcoming Episode of American Farmer on RFD-TV 2
... July 8 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics,Inc. (OTC Bulletin ... firm specializing in the manufacture, research, development,marketing ... Dr.,Shuguang Fang, China-Biotics, Chief Technology Officer, has ... China,s 3rd Annual Food Safety Technology Forum,2008 ...
... purchase, distribute US-made bulk API, BATON ... Albemarle Corporation (NYSE: ALB ), a ... and other active pharmaceutical,ingredients (APIs), has signed ... Laboratories Ltd. As per the agreement, effective,immediately, ...
... Board and Management Focused on Near-Term Milestones and Maintain ... ... DIEGO, July 8 /PRNewswire-FirstCall/ - MIGENIX Inc.,(TSX: MGI, OTC: MGIFF), ... requisition for a special meeting of shareholders,for the purpose of ...
Cached Biology Technology:China-Biotics, Inc. to Present at China's 3rd Annual Food Safety Technology Forum 2008 2China-Biotics, Inc. to Present at China's 3rd Annual Food Safety Technology Forum 2008 3Albemarle Enters Ibuprofen Agreement with Dr. Reddy's 2Albemarle Enters Ibuprofen Agreement with Dr. Reddy's 3MIGENIX Corporate Update and Requisition of Special Meeting 2MIGENIX Corporate Update and Requisition of Special Meeting 3MIGENIX Corporate Update and Requisition of Special Meeting 4MIGENIX Corporate Update and Requisition of Special Meeting 5MIGENIX Corporate Update and Requisition of Special Meeting 6MIGENIX Corporate Update and Requisition of Special Meeting 7MIGENIX Corporate Update and Requisition of Special Meeting 8
(Date:3/12/2015)... The mascots of the Atlantic Coast Conference ... Wake Forest Baptist Medical Center. They stopped by as ... Men,s Basketball Tournament. Young patients enjoyed bonding with their ... autographs. Brenner Children,s Hospital is the pediatric ... children,s hospital in northwest North Carolina ...
(Date:3/11/2015)... DUBLIN , Mar. 11, 2015 Research and ... addition of the "Access Control Market by Product, ... to 2020" report to their offering. , ... is expected to reach $10.4 billion by 2020, with ... control market report covers the products types such as ...
(Date:3/10/2015)... BOULDER, Colo. , March 10, 2015 ... Space Flight "Personalized Medicine in Human ... Ph.D. and Thomas J. Goodwin , Ph.D. was ... articles of the past two years. Specifically, ... three most downloaded scientific papers published in 2013 and ...
Breaking Biology News(10 mins):Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2
... found a key to keeping stem cells in their neutral ... published in the journal PLoS One , the researchers ... soft gel rather than on a hard plate or dish ... the ability to become any type of tissue. The soft ...
... essential to polar bears would likely respond positively should more ... a new modeling study published today in the journal, ... Geological Survey, included university and other federal agency scientists. The ... the scientific community by providing evidence that during this century ...
... production has led scientists to discover genes in yeast ... produce more ethanol from the same amount of nutrients. ... of Genetics ( http://www.genetics.org ), shows how ... a bottleneck in the production of ethanol from cellulosic ...
Cached Biology News:Soft substrate promotes pluripotent stem cell culture 2Soft substrate promotes pluripotent stem cell culture 3New study about Arctic sea-ice, greenhouse gases and polar bear habitat 2'Green genes' in yeast may boost biofuel production by increasing stress tolerance 2
... The TC-3000 is one of the smallest ... with a choice of either the 0.5ml (20 ... ,Key Features: , Fast heating and cooling ... in reliability and high performance Fast track ...
... Provides a buffered anti-freeze environment for enzyme ... a liquid, low viscosity solution at -20C ... necessary and sampling is convenient , ... long-term storage Protect enzyme conjugates during ...
A collection of 42 spots with normal tissues from different organs of C57 mice, rat and human....
... V-106 voice-coil scanning and positioning system ... samples have to be positioned or ... resolution. It provides superior responsiveness compared ... The mechanics (X or XY stage) ...
Biology Products: